[New Evidence of Efficacy and Safety of Rivaroxaban in Routine Clinical Practice].
The article contains results of two studies assessing efficacy and safety of rivaroxaban in routine clinical practice which were presented at European Congress of Cardiology 2015. These studies (recently completed XANTUS and ongoing post-marketing safety surveillance study in the United States) in total included more than 45 000 patients from Europe, Russia, Canada and the United States.